MAP2 levels decreased significantly in the SN, where neuronal loss is extensive in PD2, in both the IPD and PD-GBA groups (Fig. 2e), and to a somewhat greater extent in the STR in PD-GBA compared to IPD. Here, MAP2 is linked to Parkinson disease.